The global smart pills market reached a value of US$ 3.9 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 6.3 Billion by 2027, exhibiting at a CAGR of 7.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Smart pills are ingestible medical devices comprising sensors, cameras, patches, and trackers to record various physiological measures. They help in accurate therapy and better diagnostics and monitoring while eliminating the need for invasive procedures. Presently, several manufacturers are coming with innovative variants with advanced batteries and onboard memory. They assist in remote patient monitoring and telemedicine, providing wireless transmission of information in real-time and measuring the effects of the medication.
Smart Pills Market Trends: A considerable rise in the prevalence of cancer and malignant gastrointestinal (GI) disorders represents one of the primary factors driving the demand for smart pills over conventional diagnostic techniques, such as endoscopy. Endoscopy devices are inserted into the patient’s esophagus for diagnosis of GI disorders. However, the risk of infection transmission and esophageal tearing is usually high with endoscopes. Consequently, smart pills are widely utilized as they provide multidimensional pictures of the internal parts of the body non-invasively. Moreover, the growing pediatric population, which is relatively more vulnerable to targeted diseases, along with the emerging trend of minimally invasive surgeries (MIS), is promoting the adoption of smart pills to diagnose and treat chronic diseases. Apart from this, the coronavirus disease (COVID-19) outbreak and the consequent rise in the demand for telemedicine technologies for remote patient visits are contributing to market growth. Furthermore, they are employed in the defense and allied industries to monitor the core body temperature of soldiers in real-time. Besides this, market players are investing in research and development (R&D) projects that focus on effective localization, steering, and control of pills. This is projected to expand the applications of smart pills in the future.
Key Market Segmentation: the analyst provides an analysis of the key trends in each sub-segment of the global smart pills market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on target area, disease indication, application and end user.
Breakup by Target Area: Esophagus Small Intestine Large Intestine Stomach
Breakup by Disease Indication: Esophageal Diseases Small Bowel Diseases Colon Diseases Others
Breakup by Application: Capsule Endoscopy Drug Delivery Patient Monitoring
Breakup by End User: Hospitals Diagnostic Centers Research Institutes
Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa
Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being CapsoVision Inc., Check-Cap Ltd., General Electric Company, IntroMedic Co. Ltd., Jinshan Science & Technology (Group) Co. Ltd., Koninklijke Philips N.V., Medtronic plc, Olympus Corporation and PENTAX Medical (Hoya Corporation).
Key Questions Answered in This Report: How has the global smart pills market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global smart pills market? What are the key regional markets? What is the breakup of the market based on the target area? What is the breakup of the market based on the disease indication? What is the breakup of the market based on the application? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global smart pills market and who are the key players? What is the degree of competition in the industry?
Our reports have been used by over 10K customers, including:
200 pages •
By The Business Research Company
• May 2022
Major players in the oncology devices market are Eckert & Ziegler BEBIG, Oncura Inc, GE Healthcare, Medtronic plc, Varian Medical Systems Inc, Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, and IBA Group. The global oncology devices market is expected to grow from $91.47 billion in 2021 to $107.81 billion...
Major players in the electrosurgical devices market are Bovie Medical Corporation, Johnson & Johnson Private Limited, B. Braun Melsungen AG, Medtronic PLC, Smith and Nephew, Boston Scientific, Stryker Corporation, ATMOS Inc, Heal Force Bio-Meditech Holdings Limited, and Erbe Elektromedizin GmbH. The global electrosurgical devices and...
250 pages •
By The Business Research Company
• May 2022
Major players in the smart pills market are Medtronic Plc., Olympus Medical Technology, CapsoVision, Inc., Novartis AG, Proteus Pharmaceuticals, Philips Healthcare, Microchips, Bio-Images Drug Delivery (BDD) Limited, Given Imaging, Inc., and Vitality. The global smart pills market is expected to grow from $4.03 billion in 2021 to $4.48...
The global holographic display market reached a value of US$ 1,350 Million in 2021. Looking forward, the analyst expects the market to reach US$ 5,130 Million by 2027, exhibiting a CAGR of 25.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as...
The global analog-to-digital converters market reached a value of US$ 2.38 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 3.33 Billion by 2027, exhibiting a CAGR of 5.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...
2022 Leading Medical Device Companies Capabilities, Goals and Strategies This report is part of the Competitive Analysis Series prepared to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading competitors. The...
As the healthcare sector adapts to the changes induced by the COVID-19 pandemic, the global medical devices industry is undergoing a major transformation in terms of business models, technology adoption, and care delivery approaches, among other areas. 2022 will prove to be another challenging year for medtech as uncertainties pertaining to...
120 pages •
By Infiniti Research Limited
• Apr 2022
Global Test And Measurement Equipment Market In APAC 2022-2026 The analyst has been monitoring the test and measurement equipment market in APAC and it is poised to grow by $ 1.79 bn during 2022-2026 decelerating at a CAGR of 5.3% during the forecast period. Our report on the test and measurement equipment market in APAC...
The global medical power supply market reached a value of US$ 1.47 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 2.18 Billion by 2027, exhibiting a CAGR of 6.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
The Testing, inspection, and certification market is projected to reach USD 268.9 billion by 2027 from USD 221.4 billion in 2022; it is expected to grow at a CAGR of 4.0% from 2022 to 2027. The growth of the Testing, inspection, and certification market in APAC is mainly driven by the increasing adoption of latest technologies in the region...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.